» Articles » PMID: 23169586

Association of Coffee Consumption with Serum Adiponectin, Leptin, Inflammation and Metabolic Markers in Japanese Workers: a Cross-sectional Study

Overview
Journal Nutr Diabetes
Date 2012 Nov 22
PMID 23169586
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mechanisms underlying coffee's beneficial actions against cardiovascular disease and glucose metabolism are not well understood. Little information is available regarding association between coffee consumption and adipocytokines.

Objective: We investigated potential associations between coffee consumption and adiponectin, leptin, markers for subclinical inflammation, glucose metabolism, lipids and liver enzymes. We then investigated whether adipocytokines played a role in the association between coffee consumption and these markers.

Design And Subjects: This is a cross-sectional study comprising 2554 male and 763 female Japanese workers. Potential relations between coffee consumption and adipocytokines or other markers were evaluated using a multiple linear regression model adjusted for confounding factors. We evaluated whether adiponectin and leptin partly explain the associations between coffee consumption and each marker by multiple mediation analysis.

Results: Coffee consumption showed significant positive associations with adiponectin and total and low-density lipoprotein cholesterol, and inverse associations with leptin, high sensitivity C-reactive protein (hs-CRP), triglycerides and liver enzymes (all P<0.05). An adjustment for adiponectin and leptin significantly attenuated the associations between coffee consumption and hs-CRP or triglycerides, but not for liver enzymes. No associations were observed between coffee consumption and glucose metabolism-related markers.

Conclusion: Coffee consumption was associated with high adiponectin and low leptin levels. We speculated that adipocytokines mainly explain the associations of coffee consumption with lipids and hs-CRP. Factors other than adipocytokines may explain the association between coffee consumption and liver function.

Citing Articles

Food group intakes and high-sensitivity C-reactive protein among community-dwelling Japanese adults: a cross-sectional study.

Matsunaga T, Wakai K, Imaeda N, Goto C, Tamada Y, Kato Y Public Health Nutr. 2024; 27(1):e212.

PMID: 39420779 PMC: 11604322. DOI: 10.1017/S1368980024001599.


Association between Coffee Consumption and Polycystic Ovary Syndrome: An Exploratory Case-Control Study.

Meliani-Rodriguez A, Cutillas-Tolin A, Mendiola J, Sanchez-Ferrer M, De la Cruz-Sanchez E, Vioque J Nutrients. 2024; 16(14).

PMID: 39064680 PMC: 11279816. DOI: 10.3390/nu16142238.


Caffeine: a potential mechanism for anti-obesity.

Wang M, Guo W, Chen J Purinergic Signal. 2024; .

PMID: 38802651 DOI: 10.1007/s11302-024-10022-1.


Dietary caffeine intake is associated with favorable metabolic profile among apparently healthy overweight and obese individuals.

Alshahrani S, Atia Y, Badir R, Almalki S, Tayyib N, Shahab S BMC Endocr Disord. 2023; 23(1):227.

PMID: 37864190 PMC: 10588058. DOI: 10.1186/s12902-023-01477-1.


Association between coffee consumption and high C-reactive protein levels in Korean adults.

Choi S, Je Y Br J Nutr. 2023; 130(12):2146-2154.

PMID: 37225668 PMC: 10657750. DOI: 10.1017/S0007114523001241.


References
1.
Kim S, Kim H, Seo J, Lee K, Oh J, Kim N . Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease. Eur J Endocrinol. 2005; 152(2):225-31. DOI: 10.1530/eje.1.01842. View

2.
Fransson E, Batty G, Tabak A, Brunner E, Kumari M, Shipley M . Association between change in body composition and change in inflammatory markers: an 11-year follow-up in the Whitehall II Study. J Clin Endocrinol Metab. 2010; 95(12):5370-4. PMC: 2999966. DOI: 10.1210/jc.2010-0730. View

3.
Williams C, Fargnoli J, Hwang J, van Dam R, Blackburn G, Hu F . Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care. 2007; 31(3):504-7. PMC: 2737446. DOI: 10.2337/dc07-1952. View

4.
van Dam R, Hu F . Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 2005; 294(1):97-104. DOI: 10.1001/jama.294.1.97. View

5.
Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M . Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010; 91(4):950-7. DOI: 10.3945/ajcn.2009.28548. View